PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012
CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004
Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS) Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010
CPAP and uvulopalatopharyngoplasty (UPPP) normalized pulmonary hypertension in patients with obstructive sleep apnea (OSAS) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Non-invasive ventilation (NIV) with auto-EPAP in elderly patients with obstructive sleep apnea-hypopnea syndrome (OSAHS) Source: Sleep and Breathing Conference 2021 Year: 2021
Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA). Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020
Reliability of apnea/hypopnea index (AHI) determined by two different auto-CPAP in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects II Year: 2011
The efficacy of sidenafil and CPAP in men with obstructive sleep apnea syndrome and erectile dysfunction Source: Eur Respir J 2004; 24: Suppl. 48, 568s Year: 2004
Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy Source: Eur Respir J 2006; 28: Suppl. 50, 648s Year: 2006
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004
Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 725s Year: 2005
A study of prevalence of sleep disordered breathing (SDB) and obstructive sleep apnea-hypopnea syndrome (OSAHS) in treated, locoregionally controlled oral cancer Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010
Does sleepiness have an impact on echocardiographic parameters in obstructive sleep apnea (OSA) after 6M CPAP therapy? Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 95s Year: 2003
Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS) Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001
Outcomes in patients with REM-related obstructive sleep apnoea (REM-OSA) treated with continuous positive airway pressure (CPAP) Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019